The global market for Nucleic Acid-based Therapeutics was valued at US$ 580 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 3.9% during the forecast period.

Nucleic Acid-based Therapeutics Market

Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid-based Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid-based Therapeutics.

The Nucleic Acid-based Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid-based Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nucleic Acid-based Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nucleic Acid-based Therapeutics Market Report

Report Metric	Details
Report Name	Nucleic Acid-based Therapeutics Market
Accounted market size in year	US$ 580 million
Forecasted market size in 2031	US$ 756 million
CAGR	3.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Anti-Sense And Anti-Gene Short Inhibitory Sequences Gene Transfer Therapy Nucleoside Analogs Ribozymes Aptamers
Segment by Application	Hospitals Academic & Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene, Copernicus Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nucleic Acid-based Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nucleic Acid-based Therapeutics Market growing?

Ans: The Nucleic Acid-based Therapeutics Market witnessing a CAGR of 3.9% during the forecast period 2025-2031.

What is the Nucleic Acid-based Therapeutics Market size in 2031?

Ans: The Nucleic Acid-based Therapeutics Market size in 2031 will be US$ 756 million.

Who are the main players in the Nucleic Acid-based Therapeutics Market report?

Ans: The main players in the Nucleic Acid-based Therapeutics Market are Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene, Copernicus Therapeutics

What are the Application segmentation covered in the Nucleic Acid-based Therapeutics Market report?

Ans: The Applications covered in the Nucleic Acid-based Therapeutics Market report are Hospitals, Academic & Research Institutes

What are the Type segmentation covered in the Nucleic Acid-based Therapeutics Market report?

Ans: The Types covered in the Nucleic Acid-based Therapeutics Market report are Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Anti-Sense And Anti-Gene

1.2.3 Short Inhibitory Sequences

1.2.4 Gene Transfer Therapy

1.2.5 Nucleoside Analogs

1.2.6 Ribozymes

1.2.7 Aptamers

1.3 Market by Application

1.3.1 Global Nucleic Acid-based Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Academic & Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nucleic Acid-based Therapeutics Market Perspective (2020-2031)

2.2 Global Nucleic Acid-based Therapeutics Growth Trends by Region

2.2.1 Global Nucleic Acid-based Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nucleic Acid-based Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Nucleic Acid-based Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Nucleic Acid-based Therapeutics Market Dynamics

2.3.1 Nucleic Acid-based Therapeutics Industry Trends

2.3.2 Nucleic Acid-based Therapeutics Market Drivers

2.3.3 Nucleic Acid-based Therapeutics Market Challenges

2.3.4 Nucleic Acid-based Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nucleic Acid-based Therapeutics Players by Revenue

3.1.1 Global Top Nucleic Acid-based Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Nucleic Acid-based Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Nucleic Acid-based Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nucleic Acid-based Therapeutics Revenue

3.4 Global Nucleic Acid-based Therapeutics Market Concentration Ratio

3.4.1 Global Nucleic Acid-based Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Therapeutics Revenue in 2024

3.5 Global Key Players of Nucleic Acid-based Therapeutics Head office and Area Served

3.6 Global Key Players of Nucleic Acid-based Therapeutics, Product and Application

3.7 Global Key Players of Nucleic Acid-based Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nucleic Acid-based Therapeutics Breakdown Data by Type

4.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2026-2031)

5 Nucleic Acid-based Therapeutics Breakdown Data by Application

5.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nucleic Acid-based Therapeutics Market Size (2020-2031)

6.2 North America Nucleic Acid-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025)

6.4 North America Nucleic Acid-based Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nucleic Acid-based Therapeutics Market Size (2020-2031)

7.2 Europe Nucleic Acid-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nucleic Acid-based Therapeutics Market Size by Country (2020-2025)

7.4 Europe Nucleic Acid-based Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nucleic Acid-based Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Nucleic Acid-based Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nucleic Acid-based Therapeutics Market Size (2020-2031)

9.2 Latin America Nucleic Acid-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Nucleic Acid-based Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nucleic Acid-based Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Nucleic Acid-based Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Wave Life Sciences

11.1.1 Wave Life Sciences Company Details

11.1.2 Wave Life Sciences Business Overview

11.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Introduction

11.1.4 Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.1.5 Wave Life Sciences Recent Development

11.2 Imugene

11.2.1 Imugene Company Details

11.2.2 Imugene Business Overview

11.2.3 Imugene Nucleic Acid-based Therapeutics Introduction

11.2.4 Imugene Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.2.5 Imugene Recent Development

11.3 Caperna

11.3.1 Caperna Company Details

11.3.2 Caperna Business Overview

11.3.3 Caperna Nucleic Acid-based Therapeutics Introduction

11.3.4 Caperna Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.3.5 Caperna Recent Development

11.4 Phylogica

11.4.1 Phylogica Company Details

11.4.2 Phylogica Business Overview

11.4.3 Phylogica Nucleic Acid-based Therapeutics Introduction

11.4.4 Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.4.5 Phylogica Recent Development

11.5 Protagonist Therapeutics

11.5.1 Protagonist Therapeutics Company Details

11.5.2 Protagonist Therapeutics Business Overview

11.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Introduction

11.5.4 Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.5.5 Protagonist Therapeutics Recent Development

11.6 Benitec Biopharma

11.6.1 Benitec Biopharma Company Details

11.6.2 Benitec Biopharma Business Overview

11.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Introduction

11.6.4 Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.6.5 Benitec Biopharma Recent Development

11.7 EGEN

11.7.1 EGEN Company Details

11.7.2 EGEN Business Overview

11.7.3 EGEN Nucleic Acid-based Therapeutics Introduction

11.7.4 EGEN Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.7.5 EGEN Recent Development

11.8 BioMedica

11.8.1 BioMedica Company Details

11.8.2 BioMedica Business Overview

11.8.3 BioMedica Nucleic Acid-based Therapeutics Introduction

11.8.4 BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.8.5 BioMedica Recent Development

11.9 Transgene

11.9.1 Transgene Company Details

11.9.2 Transgene Business Overview

11.9.3 Transgene Nucleic Acid-based Therapeutics Introduction

11.9.4 Transgene Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.9.5 Transgene Recent Development

11.10 Copernicus Therapeutics

11.10.1 Copernicus Therapeutics Company Details

11.10.2 Copernicus Therapeutics Business Overview

11.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Introduction

11.10.4 Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020-2025)

11.10.5 Copernicus Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Protagonist Therapeutics

Copernicus Therapeutics

List of Tables

Table 1. Global Nucleic Acid-based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anti-Sense And Anti-Gene

Table 3. Key Players of Short Inhibitory Sequences

Table 4. Key Players of Gene Transfer Therapy

Table 5. Key Players of Nucleoside Analogs

Table 6. Key Players of Ribozymes

Table 7. Key Players of Aptamers

Table 8. Global Nucleic Acid-based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nucleic Acid-based Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Nucleic Acid-based Therapeutics Market Share by Region (2020-2025)

Table 12. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Nucleic Acid-based Therapeutics Market Share by Region (2026-2031)

Table 14. Nucleic Acid-based Therapeutics Market Trends

Table 15. Nucleic Acid-based Therapeutics Market Drivers

Table 16. Nucleic Acid-based Therapeutics Market Challenges

Table 17. Nucleic Acid-based Therapeutics Market Restraints

Table 18. Global Nucleic Acid-based Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Nucleic Acid-based Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2024)

Table 21. Ranking of Global Top Nucleic Acid-based Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Nucleic Acid-based Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Nucleic Acid-based Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Nucleic Acid-based Therapeutics, Product and Application

Table 25. Global Key Players of Nucleic Acid-based Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Nucleic Acid-based Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2020-2025)

Table 29. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Nucleic Acid-based Therapeutics Revenue Market Share by Type (2026-2031)

Table 31. Global Nucleic Acid-based Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Nucleic Acid-based Therapeutics Revenue Market Share by Application (2020-2025)

Table 33. Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Nucleic Acid-based Therapeutics Revenue Market Share by Application (2026-2031)

Table 35. North America Nucleic Acid-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Nucleic Acid-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Nucleic Acid-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Nucleic Acid-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Nucleic Acid-based Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Nucleic Acid-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Nucleic Acid-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Nucleic Acid-based Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 50. Wave Life Sciences Company Details

Table 51. Wave Life Sciences Business Overview

Table 52. Wave Life Sciences Nucleic Acid-based Therapeutics Product

Table 53. Wave Life Sciences Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 54. Wave Life Sciences Recent Development

Table 55. Imugene Company Details

Table 56. Imugene Business Overview

Table 57. Imugene Nucleic Acid-based Therapeutics Product

Table 58. Imugene Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 59. Imugene Recent Development

Table 60. Caperna Company Details

Table 61. Caperna Business Overview

Table 62. Caperna Nucleic Acid-based Therapeutics Product

Table 63. Caperna Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 64. Caperna Recent Development

Table 65. Phylogica Company Details

Table 66. Phylogica Business Overview

Table 67. Phylogica Nucleic Acid-based Therapeutics Product

Table 68. Phylogica Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 69. Phylogica Recent Development

Table 70. Protagonist Therapeutics Company Details

Table 71. Protagonist Therapeutics Business Overview

Table 72. Protagonist Therapeutics Nucleic Acid-based Therapeutics Product

Table 73. Protagonist Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 74. Protagonist Therapeutics Recent Development

Table 75. Benitec Biopharma Company Details

Table 76. Benitec Biopharma Business Overview

Table 77. Benitec Biopharma Nucleic Acid-based Therapeutics Product

Table 78. Benitec Biopharma Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 79. Benitec Biopharma Recent Development

Table 80. EGEN Company Details

Table 81. EGEN Business Overview

Table 82. EGEN Nucleic Acid-based Therapeutics Product

Table 83. EGEN Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 84. EGEN Recent Development

Table 85. BioMedica Company Details

Table 86. BioMedica Business Overview

Table 87. BioMedica Nucleic Acid-based Therapeutics Product

Table 88. BioMedica Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 89. BioMedica Recent Development

Table 90. Transgene Company Details

Table 91. Transgene Business Overview

Table 92. Transgene Nucleic Acid-based Therapeutics Product

Table 93. Transgene Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 94. Transgene Recent Development

Table 95. Copernicus Therapeutics Company Details

Table 96. Copernicus Therapeutics Business Overview

Table 97. Copernicus Therapeutics Nucleic Acid-based Therapeutics Product

Table 98. Copernicus Therapeutics Revenue in Nucleic Acid-based Therapeutics Business (2020-2025) & (US$ Million)

Table 99. Copernicus Therapeutics Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Authors List of This Report

List of Figures

Figure 1. Nucleic Acid-based Therapeutics Picture

Figure 2. Global Nucleic Acid-based Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nucleic Acid-based Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Anti-Sense And Anti-Gene Features

Figure 5. Short Inhibitory Sequences Features

Figure 6. Gene Transfer Therapy Features

Figure 7. Nucleoside Analogs Features

Figure 8. Ribozymes Features

Figure 9. Aptamers Features

Figure 10. Global Nucleic Acid-based Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Nucleic Acid-based Therapeutics Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Academic & Research Institutes Case Studies

Figure 14. Nucleic Acid-based Therapeutics Report Years Considered

Figure 15. Global Nucleic Acid-based Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nucleic Acid-based Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nucleic Acid-based Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Nucleic Acid-based Therapeutics Market Share by Players in 2024

Figure 19. Global Top Nucleic Acid-based Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nucleic Acid-based Therapeutics Revenue in 2024

Figure 21. North America Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nucleic Acid-based Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nucleic Acid-based Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nucleic Acid-based Therapeutics Market Share by Region (2020-2031)

Figure 35. China Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nucleic Acid-based Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nucleic Acid-based Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nucleic Acid-based Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Wave Life Sciences Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 51. Imugene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 52. Caperna Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 53. Phylogica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 54. Protagonist Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 55. Benitec Biopharma Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 56. EGEN Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 57. BioMedica Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 58. Transgene Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 59. Copernicus Therapeutics Revenue Growth Rate in Nucleic Acid-based Therapeutics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions